Evogene Celebrates IPO on the NYSE

 

 

Executives of Israel-based Evogene Ltd., a leading plant genomics company addressing the global demand for food, feed and fuel, will visit the New York Stock Exchange (NYSE) to celebrate the company’s initial public offering in the United States. Evogene Ltd. begins trading on the NYSE today, November 21, under the ticker symbol “EVGN”.

In honor of the occasion, Evogene Chairman Martin Gerstel, joined by President and Chief Executive Officer Ofer Haviv, rang The Opening Bell at the NYSE.

Video of the event will be available shotrly.

About Evogene Ltd. (NYSE: EVGN)

Evogene is a plant genomics company that uses a comprehensive and integrated technology infrastructure to enhance seed traits underlying crop performance and productivity through biotechnology and advanced breeding methods. The company has strategic collaborations with world-leading agricultural companies, primarily to develop traits for improved yield and abiotic stress tolerance (such as improved tolerance to drought, heat and salinity) and biotic stress resistance (such as resistance to disease, pests and insects), focusing on the world’s most essential crops, including corn, soybean, wheat, rice and cotton. In addition, Evogene has earlier-stage operations in agriculture chemicals, and seeds focusing on second generation feedstock for biodiesel. The Company is headquartered in Israel, and is listed for trading on both the Tel Aviv Stock Exchange and the New York Stock Exchange under the symbol EVGN. For additional information, please visit Evogene’s website at www.evogene.com. (Source: Evogene Ltd.)